STOCK TITAN

MariMed Announces Third Quarter 2022 Earnings Date

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

MariMed, a multi-state cannabis operator, will report its Q3 2022 financial results on November 7, 2022, after market close. A conference call is scheduled for November 8, 2022, at 8:00 a.m. EST to discuss these results. Investors can access the earnings webcast on MariMed's Investor Relations website. The company is known for its high-quality cannabis products, including award-winning brands like Betty's Eddies and Nature’s Heritage. MariMed is dedicated to improving lives through excellence in cannabis cultivation and product development.

Positive
  • Scheduled financial results reporting for Q3 2022 may enhance investor transparency.
  • Management's consistent growth and success in the cannabis market indicates solid operational performance.
Negative
  • None.

NORWOOD, Mass., Oct. 12, 2022 (GLOBE NEWSWIRE) -- MariMed, Inc. (“MariMed” or the “Company”), (CSE: MRMD), (OTCQX: MRMD), a leading multi-state cannabis operator focused on improving lives every day, today announced it will report its third quarter 2022 financial results on November 7, 2022 after the market closes. Management will host a conference call on November 8, 2022 at 8:00 a.m. EST to discuss financial results.

A webcast will be available and can be accessed via MariMed’s Investor Relations website at MariMed Q322 Earnings Webcast. To listen to the live call, please visit the website at least 15 minutes prior to the call to register, download and install any necessary audio software. A playback of the call will be archived on MariMed’s website for approximately 30 days.

About MariMed
MariMed Inc., a multi-state cannabis operator, is dedicated to improving lives every day through its high-quality products, its actions, and its values. The Company develops, owns, and manages seed to sale state-licensed cannabis facilities, which are models of excellence in horticultural principles, cannabis cultivation, cannabis-infused products, and dispensary operations. MariMed has an experienced management team that has produced consistent growth and success for the Company and its managed business units. Proprietary formulations created by the Company’s technicians are embedded in its top-selling and award-winning products and brands, including Betty's Eddies, Nature’s Heritage, Bubby’s Baked, K Fusion, Kalm Fusion, and Vibations: High + Energy. For additional information, visit www.marimedinc.com.

Investor Relations Contact:
Steve West
Vice President, Investor Relations
Email: ir@marimedinc.com
Phone: (781) 277-0007

Media Contact:
Trailblaze PR
Email: marimed@trailblaze.co 

Company Contact:
Howard Schacter
Chief Communications Officer
Email: hschacter@marimedinc.com
Phone: (781) 277-0007


FAQ

When will MariMed report its Q3 2022 financial results?

MariMed will report its Q3 2022 financial results on November 7, 2022, after market close.

What is the date and time of MariMed's earnings conference call?

The earnings conference call is scheduled for November 8, 2022, at 8:00 a.m. EST.

How can I access MariMed's Q3 2022 earnings webcast?

You can access the earnings webcast on MariMed's Investor Relations website.

What is MariMed known for?

MariMed is known for being a multi-state cannabis operator with award-winning products like Betty's Eddies and Nature’s Heritage.

MARIMED INC

OTC:MRMD

MRMD Rankings

MRMD Latest News

MRMD Stock Data

64.32M
342.15M
14.01%
0.79%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States of America
Norwood